amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1‐Linked Amyotrophic Lateral Sclerosis#465435Open Access LMU
• From neural development to regenerative medicine: A research journey in stem cell biology, spinal cord repair, and iPSC-based drug discovery#669749Europe PMC
• Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)#857283ClinicalTrials.gov
• Using the structure of genome data in the design of deep neural networks for predicting amyotrophic lateral sclerosis from genotype#779321Bielefeld Pub
• Neurodegenerative Diseases Progression Markers (MARKERS-NDD)#825305ClinicalTrials.gov
• Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis#842923ClinicalTrials.gov
• Preferences for Healthcare Delivery in Amyotrophic Lateral Sclerosis (ALS): A Survey of Patients and Caregivers in the United States#302502Springer Nature OA
• Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study#826957ClinicalTrials.gov
• Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth#1031314ClinicalTrials.gov
• SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis#1009519ClinicalTrials.gov
• Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS#1046620ClinicalTrials.gov
• Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)#843403ClinicalTrials.gov
• Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases#916900ClinicalTrials.gov
• Types and frequencies of adverse events across clinical trials for patients with amyotrophic lateral sclerosis: an analysis of the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database#208532Figshare
• UPenn Observational Research Repository on Neurodegenerative Disease#835467ClinicalTrials.gov
• COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis#899910ClinicalTrials.gov
• This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling#867967ClinicalTrials.gov
• Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.#807542ClinicalTrials.gov
• Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS#620182eScholarship
• The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder#812631ClinicalTrials.gov
• GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices#839293ClinicalTrials.gov
• Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders#840159ClinicalTrials.gov